Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

PFIZER

  • FDA Approval
  • Oct. 25, 2024, 11:59 UTC
  • 28
  • 0 comments

FDA approve HEPARIN SODIUM

Comment Full text

HOSPIRA

  • FDA Approval
  • Oct. 25, 2024, 11:59 UTC
  • 19
  • 0 comments

FDA approve HEPARIN SODIUM

Comment Full text

HIKMA

  • FDA Approval
  • Oct. 25, 2024, 11:59 UTC
  • 25
  • 0 comments

FDA approve HEPARIN SODIUM

Comment Full text

FRESENIUS KABI USA

  • FDA Approval
  • Oct. 25, 2024, 11:59 UTC
  • 28
  • 0 comments

FDA approve HEPARIN SODIUM

Comment Full text

HIKMA

  • FDA Approval
  • Oct. 25, 2024, 11:59 UTC
  • 31
  • 0 comments

FDA approve HEPARIN SODIUM

Comment Full text

FRESENIUS KABI USA

  • FDA Approval
  • Oct. 25, 2024, 11:59 UTC
  • 26
  • 0 comments

FDA approve HEPARIN SODIUM

Comment Full text

HETERO LABS LTD III

  • FDA Approval
  • Oct. 25, 2024, 11:59 UTC
  • 27
  • 0 comments

FDA approve NEVIRAPINE

Comment Full text

DR REDDYS

  • FDA Approval
  • Oct. 25, 2024, 11:59 UTC
  • 23
  • 0 comments

FDA approve HEPARIN SODIUM

Comment Full text

MACLEODS PHARMS LTD

  • FDA Approval
  • Oct. 25, 2024, 11:59 UTC
  • 26
  • 0 comments

FDA approve ESOMEPRAZOLE MAGNESIUM

Comment Full text

ASPEN GLOBAL INC

  • FDA Approval
  • Oct. 25, 2024, 11:59 UTC
  • 26
  • 0 comments

FDA approve HEPARIN SODIUM

Comment Full text
  • Previous
  • 233
  • 234
  • 235
  • 236
  • 237
  • Next

Search

News categories

  • Technical Exchange News(9921)
  • Event(412)
  • SEC News(167882)
  • FDA Approval(9362)
  • Company Report(721)
  • Business News(111714)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin